The human serotonin 2C (5-HT 2C ) receptor undergoes extensive RNA editing, generating multiple isoforms; the most prominent isoform in the human brain is the extensively edited VSV isoform. In addition, a naturally occurring single nucleotide polymorphism (SNP) is found in the coding region of the 5-HT 2C receptor gene, which converts cysteine to serine at the 23rd amino acid (C23S). To elucidate the functional consequences, pharmacological properties were evaluated in cells expressing C23 or S23 in the nonedited, INI, or edited, VSV, isoform. Confocal imaging of HEK293 cells expressing the C23 and S23 variants revealed no apparent difference in cellular localization, which was confirmed in NIH-3T3 fibroblasts by surface biotinylation. Competition binding experiments revealed comparable highaffinity agonist binding for the C23 and S23 receptors and no difference in ligand affinities in either the INI or VSV backbones. The dose-response functions for 5-HT and (7)-1-(4-iodo-2,5-dimethoxyphenyl)-2-aminopropane (DOI) to elicit phosphoinositide hydrolysis did not differ in either HEK293 or NIH-3T3 fibroblasts expressing the receptor variants. Constitutive activity, evaluated in COS-7 and HEK293 cells, also was not different. Lastly, fluorescence resonance energy transfer demonstrated homodimerization of C23 receptors, which was reproduced in cells expressing the S23 variant. We conclude that the C23S SNP in the 5-HT 2C receptor has no functional consequences, even when evaluated in the most common, edited receptor backbone. Therefore, positive associations between this polymorphism and disease states may be a consequence of linkage disequilibrium with another SNP that is involved in the disease.
INTRODUCTION
The serotonin 2C (5-HT 2C ) receptor is a seven-transmembrane G-protein-coupled receptor (GPCR) that has only been found in the brain, where it is widely expressed 1 and involved in many behavioral and physiological processes (for recent review, see Giorgetti and Tecott 2 ) . Upon activation through interactions with the heterotrimeric G-protein, G q , 3 the 5-HT 2C receptor leads to activation of phospholipase C (PLC), which cleaves phosphatidylinositol 4,5-bisphosphate into diacylglycerol and inositol 1,4,5-triphosphate. Several mechanisms exist for the generation of molecular diversity in the 5-HT 2C receptor, one of which is RNA editing. RNA editing is a post-transcriptional event in which the coding potential of primary RNA transcripts is changed by mechanisms other than splicing. The human 5-HT 2C receptor mRNA undergoes A-to-I editing at five positions, generating multiple protein isoforms with different distributions and signaling capabilities. 4 The human 5-HT 2C receptor edited isoforms, which have VSV or VGV at positions 156, 158 and 160, have been shown to exhibit a decrease in agonist potency [4] [5] [6] and constitutive activity, 4, 7 as well as altered patterns of G-protein coupling, 8 suggesting that this editing process may be used to regulate signaling tone in the brain.
Another mechanism for creating diversity is at the genetic level. A growing hypothesis is that common genetic variations may contribute significantly to the genetic risk for common disease. 9 The most common type of genetic variation is the single nucleotide polymorphism (SNP) (frequency 41%), 10 which occurs in the coding or noncoding region of the gene. SNPs may change the amino-acid coding potential of a GPCR, which could interfere with protein folding, ligand binding, interactions with G-proteins and post-translational modifications of the protein (for review, see Rana et al 11 ). The 5-HT 2C receptor has been demonstrated to have high affinity for many antidepressants such as fluoxetine 12 as well as a number of antipsychotics. 13 Therefore, since the 5-HT 2C receptor has been implicated in a variety of behavioral and neurochemical responses, genetic variations within the 5-HT 2C receptor may increase the risk of the development of psychiatric disorders such as depression, anxiety and schizophrenia or it may affect psychoactive drug treatment. In the coding region of the 5-HT 2C receptor, a cysteine (C) to serine (S) change has been identified at the 23rd amino acid (C23S).
14 The 5-HT 2C receptor C23S polymorphism has been shown to associate with many disease states. In schizophrenia, the C23S SNP has been shown to associate with a positive response to the atypical antipsychotic drug clozapine 15 and with the occurrence of tardive dyskinesia. 16 Bipolar disorder, major depression 17 and hallucinations in Alzheimer's disease 18 have also been positively associated with this polymorphism. Given that this genetic variation has been associated with numerous diseases implies that this SNP may have an actual functional consequence on the protein, thus increasing the probability of a disease. It is therefore important to examine the function of the polymorphic variant. Furthermore, since the edited VSV isoform is the principal 5-HT 2C receptor isoform found in the human brain, it is necessary to determine the properties of the C23S SNP in this edited backbone. Therefore, the purpose of this study was to examine the functional impact of the C23S polymorphism on the 5-HT 2C receptor in nonedited and edited VSV receptors expressed in three different mammalian cell lines.
RESULTS

Cellular Distribution of C23 and S23 5-HT 2C Receptors is Similar
Many SNPs in GPCRs cause improper folding of the proteins, leading to retention in the ER or Golgi and reduced receptor at the cell surface (for recent review, see Bernier et al 19 ) . In order to examine the impact of the C23S polymorphism on protein localization, HEK293 cells were transiently transfected with C23 or S23 5-HT 2C-INI /YFP cDNA and subjected to confocal imaging. C23 and S23 5-HT 2C-INI receptors showed similar fluorescence patterns with intense plasma (Table 1) . However, the competition binding curves were shallow both at C23 and S23 5-HT 2C-VSV receptors, as illustrated in Figure 3 , for the hallucinogenic agonist (7)-1-(2,5-dimethoxy-4-phenyl)-2-aminopropane (DOI), suggesting multiple affinity states of the receptors. The C23 5-HT 2C-VSV receptor curve was best fit by a two-site model with the high-affinity state having a K i of 0.7370.43 nM. The addition of the GTP analog guanosine 5 0 -(b,g-imido)-triphosphate (Gpp(NH)p) shifted the competition curve to a single, low-affinity state with a K i of 40.377.3 nM ( Figure  3a) . The S23 5-HT 2C-VSV receptor curve was also best fit by a two-site model with the high-affinity state having a K i of 1.1770.63 nM. Addition of Gpp(NH)p shifted the competition curve to a single, low-affinity state with a K i of 42.372.6 nM (Figure 3b ). The portion of high-affinity agonist binding was equal for the C23 and S23 receptors ( Table 2) . Similar results were observed with the agonists 5-HT and m-chlorophenylpiperazine (m-CPP) ( Table 2 ), but not lysergic acid diethylamide (LSD).
G-Protein Coupling and Receptor Signaling are Comparable between C23 and S23 Receptor Variants
The 5-HT 2C receptor has been shown to interact with Gproteins and activate intracellular signaling in the absence of agonist, an action termed constitutive activity. 21 RNA editing dramatically reduces constitutive activity of the There was no significant difference in band densities from total cell lysates. Optical density was measured for each band using Image J software as described in Materials and methods. 3T3: untransfected parental NIH-3T3 fibroblasts. (Figure 4a ). Similar results were observed in cell lines expressing 5-HT 2C-VSV receptors except that constitutive activity was lower (Figure 4b ), which agrees with previous studies. 7 Because cell types may differ in their signaling machinery, it was important to test an additional cell type. Therefore, we measured basal [ (Figure 6a ). Since FRET efficiency is dependent on the donor/acceptor ratio, the cells were divided into three groups based on these ratios and the mean FRET efficiency for each group was calculated (Table 3) . This was performed to provide a meaningful comparison of C23 and S23 FRET efficiencies from cells with similar donor/acceptor ratios. The results presented in Table 3 indicate that there was no difference in FRET efficiencies for C23 and S23. FRET efficiency was independent of acceptor fluorescence ( Figure  6b ), indicating that FRET was independent of receptor expression level.
DISCUSSION
The human 5-HT 2C receptor mRNA undergoes A-to-I editing at 5 positions termed A, B, C, D and E in the second intracellular loop of the receptor, 4, 6, 23 a region involved in G-protein coupling. [4] [5] [6] [7] 24, 25 This receptor also has a number of SNPs in its promoter region 26, 27 and one in the coding region.
14 The present study focused on the SNP in the coding region, which converts a cysteine to a serine at the 23rd amino acid in the N-terminus of the receptor. This polymorphism occurs at a frequency of 13% in the Caucasian population 14 and has been associated with numerous disease symptoms (for recent review, see Sanders-Bush et al 28 ) . Therefore, this paper addresses the functional consequences of the combination of RNA editing and the C23S polymorphism in the human 5-HT 2C receptor. A recent study by Okada et al 29 demonstrated that the C23S SNP in the 5-HT 2C receptor was functional, but here we report that the C23S SNP has no functional consequences, even when expressed in the VSV backbone, the most prominent isoform in the human brain. These negative data, which were reproduced in three cell lines and two laboratories, may suggest a different strategy for future genetic studies.
Nonsynonymous SNPs change the amino-acid coding potential of a protein, which may lead to an alteration in conformation of the protein. This amino-acid change can lead to an unstable protein that may be retained in the endoplasmic reticulum, thereby decreasing the amount of receptor on the surface available to interact with agonist. 30, 31 The current confocal imaging studies in HEK293 cell transients demonstrated that the pattern of cellular localization of S23 5-HT 2C-INI receptors mimics that found for C23 5-HT 2C-INI receptors. In order to answer more quantitatively whether the C23S SNP altered cell surface expression, cellular distribution was evaluated by cell surface biotinylation and isolation of biotinylated surface proteins with streptavidin beads. Probing immunoblots with a human 5-HT 2C receptor antibody revealed equivalent levels of cell surface biotinylated protein in cells expressing the C23 or S23 5-HT 2C-INI or 5-HT 2C-VSV receptors. All isoforms of the protein migrated at similar molecular weights as diffuse bands revealing that glycosylation is intact. This agrees with previous studies of the 5-HT 2C receptor. Altogether, these data suggest that protein processing and targeting are not altered by the C23S polymorphism.
The present study found that NIH-3T3 fibroblasts and HEK293 cells expressing S23 5-HT 2C receptors were able to bind all ligands tested with similar affinities to that of C23 5-HT 2C receptors. In NIH-3T3 fibroblasts with equivalent receptor densities, competition binding curves for the agonists 5-HT, DOI and m-CPP were shallow and best fit by a two-site model, suggesting that both C23 and S23 receptors can bind agonists in the G-protein-coupled and -uncoupled states. In order to test this hypothesis, a nonhydrolyzable GTP analog, Gpp(NH)p, was added. Gpp(NH)p shifted agonist competition curves to a single low-affinity state, confirming that agonists were binding with high and low affinity, and that agonist high-affinity binding was not altered in cells expressing the S23 5-HT 2C receptors. In an independent study, HEK293 cells were transiently transfected with C23 or S23 5-HT 2C-INI receptor cDNA and agonist competition binding experiments were performed. Again, none of the ligands tested showed a significant difference between C23 and S23 receptors (data not shown). Okada et al 29 demonstrated increased highaffinity binding to 5-HT and m-CPP at S23 5-HT 2C-INI receptors. Although statistically significant, the differences found were small and may not be biologically significant. Both mutagenesis and biochemical studies with a variety of class A GPCRs suggest that receptor activation by ligand binding involves disruption of strong ionic interactions in transmembrane helices 3 and 6. 32 These studies are consistent with our data showing that an SNP in the Nterminus of the 5-HT 2C receptor does not alter binding. It is very unlikely that an SNP in the N-terminus would change the binding affinity of the 5-HT 2C receptor, unless it was accompanied with an extensive conformational change. If a conformational change such as this did take place, one might expect that trafficking or G-protein coupling would be altered, but this was not found. Therefore, our data led us to conclude that the S23 allele does not alter ligand binding.
The 5-HT 2C receptor has been shown to exhibit prominent constitutive activity, 21 defined as the ability of a receptor to bind its cognate G-protein and activate signaling in the absence of agonist. Constitutive activity in the 5-HT 2C receptor has been shown to be dramatically reduced as a consequence of RNA editing. 4, 7 In the current studies, we found that COS-7 cells transiently transfected with 5-HT 2C-VSV receptors, in agreement with previous studies. 4, 7 However, there was no significant difference in basal activity between C23 and S23 receptors, whether in the INI or VSV backbone. To address the possibility that a functional consequence could be cell type dependent, we examined constitutive activity in HEK293 cells and found no difference at multiple receptor densities. Okada et al 29 found that S23 5-HT 2C-INI receptors had increased constitutive activity compared to wild-type receptors, using in vitro reconstitution of receptors expressed in Sf9 insect cells with squid Gaq and bovine Gbg subunits. However, these differences found utilizing purified proteins in vitro are not reproduced in intact cells; our studies showed that C23 and S23 5-HT 2C receptors have similar constitutive activities in intact mammalian cells.
In the present study, PLC activation was examined in NIH-3T3 transients to compare downstream signaling in the C23 vs the S23 5-HT 2C-INI receptor. Activation with 5-HT and DOI gave similar dose-response curves at C23 and S23 receptors with no differences in potency or maximal response. This was also replicated in stable cell lines expressing the INI or VSV isoform (data not shown). In addition, HEK293 cells transiently expressing 5-HT 2C-INI receptor showed no difference in the potency or maximal response to 5-HT. Taken together, these data suggest that the C23 and S23 5-HT 2C receptors have comparable signaling capabilities. However, it is possible that there could be differences in other signaling pathways that the 5-HT 2C receptor is known to activate such as PLD or PLA 2 .
The 5-HT 2C receptor has been reported to form homodimers/oligomers, 33 as has been found for other G-proteincoupled receptors (reviewed by Angers et al 34 ). 5-HT 2C receptor dimerization can be visualized on the plasma membrane of living cells using FRET combined with confocal microscopy. 33 FRET occurs when the light emitted from a laser-excited donor is transferred to an acceptor, resulting in excitation of the acceptor and quenching of the donor. In order for this interaction to occur, the donor and acceptor must have overlapping emission and excitation spectra, and they must be within 1-10 nm of each other with their dipoles oriented appropriately for energy transfer. 35 When the acceptor is removed by photobleaching, the donor becomes dequenched and FRET is measured as an increase in donor fluorescence. In the current study, FRET efficiencies were measured by acceptor photobleaching on the plasma membrane of cells expressing C23 or S23 5-HT 2C-INI receptors to determine if the C23S polymorphism alters the ability of the receptor to form homodimers/ oligomers. FRET can result from specific protein : protein interactions, such as dimer/oligomer formation (receptors in a clustered distribution), or from high levels of donor and acceptor in close enough proximity to produce FRET because they are tightly packed in a small region of the membrane (random proximity effect). Recent studies examining these two models have suggested that FRET resulting from random proximity of donor and acceptor is dependent on the amount of acceptor expressed on the plasma membrane, while FRET resulting from clustered proteins should be independent of acceptor expression levels and dependent on the ratio of donor to acceptor. 36, 37 In the present study, FRET efficiency was dependent on the donor/ acceptor ratio and independent of acceptor expression, suggesting that FRET resulted from receptors in a clustered distribution on the plasma membrane and not from receptor overexpression. When FRET efficiencies were compared in cells with similar donor/acceptor ratios, there was no difference in the amount of FRET measured on the plasma membrane of cells expressing C23 or S23 5-HT 2C-INI receptors. These results suggest that the C23S polymorphism does not alter the ability of the 5-HT 2C receptor to form homodimers. The current study is important to the field given the number of association studies examining the C23S polymorphism with neuropsychiatric disorders. This SNP occurs at a frequency of 13% in the Caucasian population 14 and has been reported at even higher frequencies in other populations. 17, 38 The C23S polymorphism has been found to be positively associated with disease symptoms and drug responses in schizophrenia, unipolar depression, bipolar disorder and Alzheimer's disease (for recent review, see Sanders-Bush et al 28 ) . The underlying causes of these associations are unknown. Since there appears to be no biologically relevant difference in the function of the C23S SNP, positive associations are likely due to linkage disequilibrium between this SNP and the causative SNP which could be in another position of the 5-HT 2C receptor gene or in another gene. However, our studies were performed in nonneuronal cell lines and it is possible that functional differences might actually exist in neurons.
In summary, using multiple stable and transient cell lines generated from different plasmid constructs and in different laboratories, we have data from three mammalian cell types documenting no functional consequence of the C23S polymorphism in the human 5-HT 2C receptor in either the nonedited INI or the edited VSV isoform, which is the principal isoform in the human brain. 4 No differences between the C23 and the S23 allele were detected in a number of experimental parameters, including radioligand binding, immunolocalization, cell surface targeting, receptor dimerization, constitutive activity and agonist-promoted phosphoinositide hydrolysis. These results do not agree with a recent report by Okada et al, 29 who reported that the Ser23 variant has increased constitutive activity in reconstitution experiments, utilizing 5-HT 2C receptors expressed in insect cells. Although constitutive activity was increased in the S23 receptor variant in this unnatural preparation, our results show that this difference is not reproduced in intact mammalian cells.
MATERIALS AND METHODS
Site-Directed Mutagenesis
Human 5-HT 2C receptor variants were prepared by PCR sitedirected mutagenesis. PCR amplification was executed with two primer sets in two rounds. Each set consisted of a primer containing the SNP and a flanking primer. The expression vector Bluescript (Stratagene, La Jolla, CA, USA) containing wild-type human 5-HT 2C receptor (INI or VSV) served as the template. Once amplified by recombinant Pfu polymerase (Promega, Madison, WI, USA), the mutated region was cut with the restriction enzymes EcoRI and AvrII and ligated into wild-type cDNA to generate the full-length expression construct. S23 receptors were verified by restriction digests and ABI 310 automated DNA sequencing. The entire receptor sequence containing the S23 SNP was cut out with EcoRI and XbaI and ligated into the mammalian expression vector pCMV2 (a gift of Dr David Russell).
Expression and Cell Culture
In order to make stable cell lines, NIH-3T3 fibroblasts were transfected by co-electroporation of pCMV2 containing C23 or S23 5-HT 2C-INI or 5-HT 2C-VSV receptor cDNA and empty pcDNA3 plasmid (0.3 mg; Invitrogen, Carlsbad, CA, USA) using the Bio-Rad Gene Pulser II. Cells with the receptor were initially selected in Dulbecco's modified Eagle's medium (DMEM; GIBCO, Grand Island, NY, USA) supplemented with 10% bovine calf serum (Hyclone Laboratories, Logan, UT, USA), antibiotics (5 U/ml penicillin and 5 mg/ml streptomycin; Life Technologies Inc.) and 2 mg/ml G418 (Geneticin, Life Technologies Inc.). The concentration of G418 was then gradually decreased to 0.5 mg/ml and stable cell lines were maintained in this medium at 371C with 5% 
Human 5-HT 2C Receptor Antibody
In order to generate antibodies to the human 5-HT 2C receptor, peptides were directed against the C-terminus of the receptor as described previously. 39 Briefly, rabbits were immunized with constructs containing the human 2C-CT peptide and purified using two columns. Serum was passed through a column containing the rat 2C-CT peptide and the flow-through applied to a second column containing the human 2C-CT peptide. Thus, the anti-human antibodies have considerably higher reactivity against human receptors relative to rat receptors. 
Surface Biotinylation and Western Blotting
For each receptor variant, one 100 mm plate of NIH-3T3 stable cell line was serum starved 16 h prior to assay. After aspiration of medium, the plates were washed three times with cold Hanks' balanced salt solution (HBSS). Sulfo-NHS-SS-Biotin in HBSS (1 mg/ml; Pierce, Rockford, IL, USA) was added (total volume ¼ 2 ml) and incubated at 41C for 20 min while rocking. The biotin solution was aspirated and 2 ml of fresh biotin solution (1 mg/ml) was added for an additional 20 min at 41C. After aspiration of the biotin solution, cells were washed three times with cold HBSS and scraped into phosphate-EDTA buffer (PE; 0.04 M NaH 2 PO 4 , 0.01 M Na 2 H-PO 4 , 0.01 M disodium EDTA, 0.002 M EGTA, pH 7.2) with 0.5 mg/ml leupeptin and 100 mM PMSF. Cell were then sonicated for 5 s and centrifuged at 16 000 g for 10 min. Pellets were resuspended in 1 ml PE-CHAPS (PE plus 0.01 M CHAPS) with 0.5 mg/ml leupeptin and 100 mM PMSF, sonicated for 5 s and incubated on ice for 30 min. Samples were then centrifuged at 16 000 g for 10 min at 41C and the BCA protein assay (Pierce) performed on the supernatants. After dilution to equal protein concentrations, 30 ml aliquots of each sample were set aside for future Western analyses. The remainder of the sample was added to 100 ml of immobilized streptavidin beads (Pierce) and rocked at 41C for 1 h. Streptavidin-biotin complexes were separated by centrifugation at 16 000 g for 2 min and washed three times with 1 ml of PE-CHAPs buffer. Biotinylated proteins were eluted from the complex by adding sample buffer containing 50 mM DTT and incubating at 501C for 40 min. Samples were resolved on a 10% SDS-PAGE precast minigels (Cambrex Bio Science, Rockland, ME, USA) and proteins transferred to nitrocellulose. Nitrocellulose membranes were washed and blocked by incubation in 3% BSA for 1 h and subsequently incubated with a primary antibody directed against the Cterminus of the human 5-HT 2C receptor (2 mg/ml) for 1.5 h. After washing three times, the membranes were incubated with alkaline-phosphatase-conjugated goat anti-rabbit secondary antibody (1 : 1000; Dako, Carpinteria, CA, USA) for 1 h. Receptor protein was detected with nitro-blue tetrazolium chloride and 5-bromo-4-chloro-3 0 -indolyphosphate (Pierce) in buffer (100 mM Tris, 100 mM NaCl, 5 mM MgCl 2 , pH 9.5).
Quantification of Immunoblots
Protein band densities were scanned on an Epson Expression 636 scanner and quantified using the public domain Image J program developed at the National Institutes of Health. Graphs represent the mean optical density from three different experiments. Student's t-test (two-tailed) was used to compare the means of the band densities.
Radioligand Binding
Membranes were prepared after washing cells with HBSS ( þ Ca 2 þ /Mg 2 þ ). Ice-cold binding buffer (50 mM Tris, 10 mM MgCl 2 , pH 7.4) was added and cells were scraped off plates and placed in ultracentrifuge tubes. After brief homogenization (2 s with a Polytron), the membranes were spun at 20 000 g for 20 min at 41C. The pellet was resuspended in binding buffer and protein concentrations were determined with the Bio-Rad protein assay. For saturation experiments, 500 ml (50 mg) of membrane preparation, 50 ml of 50 mM Tris buffer and 50 ml of varied concentrations of [N 6 -methyl- 3 H]-mesulergine (Amersham Pharmacia Biotech, UK) were mixed together and incubated at 371C for 30 min. Competition binding was carried out on membranes prepared as described above and incubated with 1 nM [ 3 H]-mesulergine and varying concentrations of competitor. Nonspecific binding was determined with 10 mM methysergide. Following incubation, free drug was separated from bound drug by vacuum filtration onto Whatman GF/C glass filters (Brandel, Gaithersburg, MD, USA). The filters were placed in scintillation vials and counted on a Packard Tri-Carb scintillation counter (Packard Instrument Company, Downers Grove, IL, USA). B max and K D values were determined from saturation isotherms using GraphPad Prism (GraphPad Software Inc., San Diego, CA, USA). In some competition binding experiments, 100 mM Gpp(NH)p was added to shift all receptors to the low-affinity state. IC 50 values were determined by fitting data to a sigmoidal curve with variable slope using GraphPad Prism; one-and two-site binding curves were compared using the F ratio. IC 50 values were converted to K i values using the transformation of Cheng and Prusoff. 40 Student's t-test (two-tailed) was used to compare the means of the K i values and means of % highaffinity binding.
Phosphoinositide Hydrolysis
For transients, 24 h post-transfection, cells were washed and then incubated for 16-20 h in serum-free, inositol-free DMEM with 1 mCi myo-[ 3 H]inositol/ml (20-25 Ci/mmol; NEN Life Science Products). The experiment was initiated after adding 10 mM lithium chloride and 10 mM pargyline and incubating for 15 min at 371C. Agonist (either 5-HT or DOI) was added and plates were incubated for an additional 30 min at 371C. The reaction was stopped by aspirating the medium and fixing the cells with 50 ml of methanol per well. [ 3 H]-inositol monophosphates were isolated as described previously. 21 The data were analyzed with GraphPad Prism 3.0 software to determine maximum responses and EC 50 values.
Fluorescence Resonance Energy Transfer CFP and YFP fluorescent tags were attached to the Cterminus of the 5-HT2C receptor as described previously. The cells were viewed live in PBS using a Zeiss LSM-510 META confocal imaging system with a 30 mW argon laser and 63 Â 1.4 NA oil immersion objective. FRET was measured by acceptor photobleaching 41 using linear unmixing of CFP and YFP emission spectra as described previously. 33 Briefly, confocal microscopy was used to isolate a 2-mm-thick optical section through the middle of a live cell expressing Signaling properties of C23S SNP in the 5-HT 2C receptor both 5-HT 2C-INI /CFP and 5-HT 2C-INI /YFP. A prebleach image was captured using an argon laser with a 458 nm/514 nm dual dichroic. A region of the plasma membrane was scanned with the 514 nm laser (100% intensity) for 30 s to photobleach YFP, and postbleach images were captured. FRET was measured as an increase in CFP fluorescence intensity (donor dequenching) following YFP photobleaching. FRET efficiency was calculated as follows: 100(CFP postbleachÀCFP prebleach)/CFP postbleach. Donor/acceptor ratios were calculated as donor fluorescence divided by acceptor fluorescence, measured prior to photobleaching. FRET efficiencies measured in 10 cells transfected with 5-HT 2C-INI /CFP alone ranged from À3.6 to þ 2.9%, with an average of 0.3%. Similar results were obtained from nonbleached regions of the plasma membrane.
